SCHEMBL24200227

SCHEMBL24200227

CCOC(=O)Cc1ccc(F)cc1O/C(F)=C/C(Br)=C(/O)CC

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ NPSR1 Q6W5P4 2/20 0.34
▸ POLB P06746 2/20 0.34
▸ HPGD P15428 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ PTGS2 P35354 3/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ MAPT P10636 2/20 0.33
▸ CYP1A2 P05177 2/20 0.33
▸ LMNA P02545 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ PTGS1 P23219 1/20 0.32
▸ TBXAS1 P24557 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.31
▸ PPARG P37231 1/20 0.31
▸ RAB9A P51151 1/20 0.31
▸ PKM P14618 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25919838 0.90 MEN1 (0.34) MEN1KMT2ANPSR1POLBHPGD
SCHEMBL21455829 0.90 MEN1 (0.34) MEN1KMT2ANPSR1POLBHPGD
SCHEMBL21455958 0.90 MAPT (0.32) MEN1KMT2AALDH1A1MAPTLMNA
SCHEMBL24199970 0.89 PTGS2 (0.34) MEN1KMT2ANPSR1POLBHPGD
SCHEMBL24200253 0.88 ALDH1A1 (0.39) MEN1KMT2APOLBHPGDALDH1A1
SCHEMBL25918089 0.88 ALDH1A1 (0.39) MEN1KMT2APOLBHPGDALDH1A1
SCHEMBL21561946 0.81 MEN1 (0.33) MEN1KMT2ANPSR1POLBHPGD
SCHEMBL21455199 0.81 MAOB (0.35) MEN1KMT2ANPSR1POLBHPGD
SCHEMBL25918206 0.81 MAOB (0.35) MEN1KMT2ANPSR1POLBHPGD
SCHEMBL24200127 0.81 MEN1 (0.35) MEN1KMT2AALDH1A1MAPTCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3939658-A1 SUBSTITUTED BENZOFURAN, BENZOPYRROLE, BENZOTHIOPHENE, AND STRUCTURALLY RELATED COMPLEMENT INHIBITORS Biocryst Pharmaceuticals, Inc. (US) 2022-01-19 — — EP disclosed
Send feedback